FIB-4 Improves LSM-Based Prediction of Complications in Overweight or Obese Patients With Compensated Advanced Chronic Liver Disease

Clin Gastroenterol Hepatol. 2022 Oct;20(10):2396-2398.e3. doi: 10.1016/j.cgh.2021.03.007. Epub 2021 Mar 11.

Abstract

Liver stiffness measurement (LSM) by transient elastography (TE) is able to stratify the risk of decompensation in patients with compensated advanced chronic liver disease (cACLD).1 Recently, we demonstrated that this holds true also in overweight or obese patients with cACLD due to nonalcoholic steatohepatitis (NASH) studied by the XL probe. An LSM cutoff of ≥21 kPa remained associated with a high risk of complications in this population.2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Elasticity Imaging Techniques*
  • Humans
  • Liver / diagnostic imaging
  • Liver / pathology
  • Liver Cirrhosis / complications
  • Non-alcoholic Fatty Liver Disease* / complications
  • Non-alcoholic Fatty Liver Disease* / pathology
  • Obesity / complications
  • Obesity / pathology
  • Overweight / complications
  • Overweight / pathology